BioCryst Pharmaceuticals, Inc. (BCRX)
7.65
-0.13
(-1.67%)
USD |
NASDAQ |
Oct 23, 16:00
7.64
-0.01
(-0.13%)
After-Hours: 20:00
BioCryst Pharmaceuticals Price : 7.65 for Oct. 23, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | 7.71 | 7.764 | 7.52 | 7.65 | 2.746M |
| Oct 22, 2026 | 7.78 | 7.88 | 7.66 | 7.78 | 4.806M |
| Oct 21, 2026 | 8.04 | 8.05 | 7.73 | 7.75 | 5.034M |
| Oct 20, 2026 | 8.11 | 8.13 | 7.84 | 7.94 | 8.455M |
| Oct 19, 2026 | 7.77 | 8.09 | 7.77 | 8.07 | 9.774M |
| Oct 16, 2026 | 7.96 | 8.015 | 7.74 | 7.79 | 4.431M |
| Oct 15, 2026 | 8.105 | 8.24 | 7.945 | 8.02 | 4.504M |
| Oct 14, 2026 | 8.02 | 8.18 | 7.97 | 8.05 | 5.650M |
| Oct 13, 2026 | 8.22 | 8.315 | 8.06 | 8.07 | 3.043M |
| Oct 12, 2026 | 8.49 | 8.55 | 8.24 | 8.36 | 3.467M |
| Oct 09, 2026 | 8.27 | 8.595 | 8.27 | 8.55 | 2.308M |
| Oct 08, 2026 | 8.36 | 8.40 | 8.13 | 8.29 | 5.122M |
| Oct 07, 2026 | 7.91 | 8.425 | 7.86 | 8.40 | 5.123M |
| Oct 06, 2026 | 8.15 | 8.15 | 7.87 | 7.95 | 3.944M |
| Oct 05, 2026 | 8.17 | 8.25 | 7.915 | 8.10 | 4.712M |
| Oct 02, 2026 | 8.12 | 8.20 | 7.92 | 8.17 | 6.149M |
| Oct 01, 2026 | 8.30 | 8.38 | 8.065 | 8.12 | 6.870M |
| Sep 30, 2026 | 8.28 | 8.42 | 8.184 | 8.33 | 13.10M |
| Sep 29, 2026 | 8.42 | 8.50 | 8.22 | 8.27 | 5.006M |
| Sep 28, 2026 | 8.555 | 8.66 | 8.335 | 8.47 | 4.355M |
| Sep 25, 2026 | 8.52 | 8.63 | 8.40 | 8.59 | 3.667M |
| Sep 24, 2026 | 8.535 | 8.65 | 8.395 | 8.52 | 4.854M |
| Sep 23, 2026 | 8.75 | 8.86 | 8.455 | 8.57 | 4.467M |
| Sep 22, 2026 | 8.87 | 9.035 | 8.72 | 8.78 | 3.442M |
| Sep 21, 2026 | 8.75 | 8.845 | 8.575 | 8.76 | 3.463M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Amgen, Inc. | 439.26 |
| Halozyme Therapeutics, Inc. | 125.63 |
| Neurocrine Biosciences, Inc. | 142.70 |
| Agenus, Inc. | 6.33 |
| Anika Therapeutics, Inc. | 21.42 |
Price Related Metrics
| PS Ratio | 1.925 |
| PEG Ratio | -0.0066 |
| Price to Free Cash Flow | 5.082 |
| Earnings Yield | -19.66% |
| Market Cap | 1.953B |
| PEGY Ratio | -0.0066 |
| Operating PE Ratio | 4.707 |
| Normalized PE Ratio | 13.70 |